Total Payments
$1,216
2024 Payments
$169.04
Companies
23
Transactions
52
Medicare Patients
793
Medicare Billing
$98,027
Payment Breakdown by Category
Food & Beverage$1,117 (91.9%)
Education$99.00 (8.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,117 | 51 | 91.9% |
| Education | $99.00 | 1 | 8.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $187.80 | 10 | $0 (2023) |
| ABBVIE INC. | $128.23 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $125.00 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $112.59 | 7 | $0 (2020) |
| Merck Sharp & Dohme LLC | $88.56 | 5 | $0 (2024) |
| Exelixis Inc. | $87.32 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $86.52 | 3 | $0 (2024) |
| PFIZER INC. | $54.00 | 4 | $0 (2018) |
| Celgene Corporation | $37.11 | 2 | $0 (2018) |
| Amgen Inc. | $36.65 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $169.04 | 6 | GlaxoSmithKline, LLC. ($86.52) |
| 2023 | $105.29 | 2 | Exelixis Inc. ($87.32) |
| 2022 | $28.07 | 1 | Foundation Medicine, Inc. ($28.07) |
| 2021 | $99.00 | 1 | ABBVIE INC. ($99.00) |
| 2020 | $63.87 | 3 | Roche Diagnostics Corporation ($24.09) |
| 2019 | $149.32 | 9 | AstraZeneca Pharmaceuticals LP ($56.86) |
| 2018 | $182.80 | 11 | E.R. Squibb & Sons, L.L.C. ($53.26) |
| 2017 | $418.15 | 19 | Otsuka America Pharmaceutical, Inc. ($125.00) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: ONCOLOGY | ||||||
| 09/21/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: Surgical Care | ||||||
| 08/08/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $31.60 | General |
| Category: ONCOLOGY | ||||||
| 03/27/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.97 | General |
| Category: Cardiovascular | ||||||
| 09/29/2023 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $87.32 | General |
| Category: Oncology | ||||||
| 11/17/2022 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2021 | ABBVIE INC. | VENCLEXTA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2020 | Roche Diagnostics Corporation | TD BenchMark IHC/ISH and Special Stains Reagents (Device) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Tissue Diagnostics | ||||||
| 02/24/2020 | Ipsen Biopharmaceuticals, Inc | SOMATULINE DEPOT (Drug), ONIVYDE | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Oncology/Endocrinology | ||||||
| 01/27/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.88 | General |
| 10/15/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Oncology | ||||||
| 09/09/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Oncology | ||||||
| 07/15/2019 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Oncology | ||||||
| 07/05/2019 | GENZYME CORPORATION | ELITEK (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: ONCOLOGY | ||||||
| 06/24/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Oncology | ||||||
| 06/17/2019 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Immunology | ||||||
| 06/10/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Oncology | ||||||
| 03/18/2019 | Amgen Inc. | Neulasta (Biological), Vectibix | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Oncology | ||||||
| 01/28/2019 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $16.50 | General |
| Category: Hematology/Oncology | ||||||
| 12/10/2018 | Novartis Pharmaceuticals Corporation | SANDOSTATIN LAR (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2018 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Hematology / Oncology | ||||||
| 04/30/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.71 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 395 | 658 | $125,025 | $50,620 |
| 2022 | 6 | 373 | 530 | $91,699 | $44,230 |
| 2021 | 2 | 25 | 34 | $6,069 | $3,178 |
Total Patients
793
Total Services
1,222
Medicare Billing
$98,027
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 204 | 370 | $61,382 | $24,847 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 56 | 123 | $20,418 | $8,332 | 40.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 55 | $12,320 | $5,501 | 44.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $8,372 | $3,652 | 43.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $10,101 | $3,576 | 35.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 15 | $4,914 | $2,044 | 41.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 16 | $3,584 | $1,682 | 46.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 13 | 14 | $3,934 | $985.40 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 235 | $35,481 | $17,157 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 63 | 117 | $17,663 | $8,094 | 45.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 42 | $8,645 | $4,669 | 54.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 22 | 38 | $7,752 | $3,994 | 51.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $8,695 | $3,580 | 41.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $5,851 | $2,874 | 49.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $3,223 | $1,585 | 49.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 17 | 17 | $2,465 | $1,253 | 50.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 13 | $1,924 | $1,025 | 53.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 14 | 21 | $4,158 | $2,222 | 53.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 11 | 13 | $1,911 | $955.24 | 50.0% |
About Dr. Fang Liu, M.D
Dr. Fang Liu, M.D is a Hematology & Oncology healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2015. The National Provider Identifier (NPI) number assigned to this provider is 1932581535.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fang Liu, M.D has received a total of $1,216 in payments from pharmaceutical and medical device companies, with $169.04 received in 2024. These payments were reported across 52 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,117).
As a Medicare-enrolled provider, Liu has provided services to 793 Medicare beneficiaries, totaling 1,222 services with total Medicare billing of $98,027. Data is available for 3 years (2021–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Marietta, GA
- Active Since 06/19/2015
- Last Updated 10/29/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1932581535
Products in Payments
- ELIQUIS (Drug) $163.08
- ABILIFY MAINTENA (Drug) $125.00
- VENCLEXTA (Drug) $99.00
- CABOMETYX (Drug) $87.32
- JEMPERLI (Biological) $86.52
- PNEUMOVAX 23 (Biological) $62.47
- TAGRISSO (Drug) $56.86
- BRILINTA (Drug) $48.85
- CHANTIX (Drug) $40.13
- Revlimid (Drug) $37.11
- ELAHERE (Drug) $29.23
- FOUNDATIONONE (Device) $28.07
- PERCLOT (Device) $27.20
- KEYTRUDA (Biological) $26.09
- TD BenchMark IHC/ISH and Special Stains Reagents (Device) $24.09
- LANTUS (Drug) $23.50
- SOMATULINE DEPOT (Drug) $22.90
- Kyprolis (Biological) $22.70
- SOLIRIS (Drug) $22.22
- OPDIVO (Biological) $20.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Marietta
Dr. Steven Mccune, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $492,856
Hematology & Oncology $492,856
Dr. Gena Volas-Redd, Md, MD
Hematology & Oncology — Payments: $115,709
Hematology & Oncology $115,709
Dr. John French, Md, MD
Hematology & Oncology — Payments: $70,611
Hematology & Oncology $70,611
Dr. Louis Garrot, M.d, M.D
Hematology & Oncology — Payments: $57,738
Hematology & Oncology $57,738
Vivek Abhyankar, Md, MD
Hematology & Oncology — Payments: $53,680
Hematology & Oncology $53,680
Dr. Dean Kirkel, Md, MD
Hematology & Oncology — Payments: $53,593
Hematology & Oncology $53,593